Navigatie

• Onderwijs
  • Toekomstige studenten
  • Studenten
  • Levenslang leren
  • Studeren in het buitenland
  • Opleidingen
  • Faculteiten
  • Inschrijvingen
  • Visie en beleid
• Onderzoek
  • Onderzoek aan de KU Leuven
  • Ondersteuning en financiering
  • Overheid, bedrijf en maatschappij
  • Doctorandi
  • Postdoctorale onderzoekers
  • Output en impact
  • Netwerken
  • Visie en beleid
• Maatschappelijke rol
  • Denktank Metaforum
  • Opiniebijdragen
  • Wetenschap voor iedereen
  • Tech transfer (LRD)
  • Universitaire Ziekenhuizen
  • Ontwikkelings-samenwerking
  • Universitaire parochie
• Over KU Leuven
  • Opdrachtverklaring
  • Feiten en cijfers
  • Gelijke kansen
  • Vacatures
  • Alumni
  • Mecenaat en fondsenwerving
  • Service en ondersteuning
  • Bestuur
  • Kulak
  • Associatie KU Leuven
  • Internationale netwerken
• KU Leuven 2013
  • Integratie
  • University Colleges
  • Tijdlijn
  • Integratie in cijfers

Funding

 

 

 

GRANTS

Funding through the University

• IOF-hefboomproject: Defective autophagy and multiple organ failure during critical illnesrds a novel life-saving therapy (01/10/2010 - 30/09/2011)
• IOF-hefboomproject: Clinical validation and filing for regulatory approval of a blood glucosator for the Intensive Care Unit. (01/08/2010 - 30/07/2011)
• METHUSALEM - Research Fund of the K.U.Leuven: Endocrine and metabolic aspects of organ failure in critical illness: perspectives for prevention and therapy. (2008 – 2015)
• GOA - Research Fund of the K.U.Leuven: On the altered endocrine and metabolic status of the critically ill: impact on organ function and survival – mechanisms of action. Grant nr. GOA 2007/14 (/2006 - 2011)
• IDO - Research Fund of the K.U.Leuven: Developing significant predictive models in critical illness. Grant nr. IDO 03/006 (2004 - 2007)
• OT - Research Fund of the K.U.Leuven: Life-saving effects of intensive insulin therapy in the critically ill: mechanisms of action. Grant nr. OT/03/56 (2003-2007)
• OT - Research Fund of the K.U.Leuven: Grant nr. OT/99/32 (1999-2003)
• OT - Research Fund of the K.U.Leuven: Grant nr. OT/95/24 (1995-1999)

National Funding

• FWO-Fund for Scientific Research, Flanders, Belgium - Metabolic stress, mitochondrial dynamics and organ failure during critical illness: towards a novel therapeutic intervention (2011-2014).
• FWO - Fund for Scientific Research, Flanders, Belgium - Clinical prediction models in intensive care (2011-2014)
• FWO - Fund for Scientific Research, Flanders, Belgium - Metabolic aspects of organ failure in critical illness: role of blood glucose levels and variation of nutritional intake.  G.0585.09 (2009-2012)
• FWO - Fund for Scientific Research, Flanders, Belgium - Regulation of the thyroid axis during critical illness: a study of the peripheral changes during the low T3 syndrome - exploring safe reactivation strategies. G.0578.09 (2009-2012)
• TBM - Institute for Science and Technology (IWT) - Tight glycaemic control with intensive insulin therapy in critically ill children: impact on acute and long-term outcome. (2008 - 2011)
• FWO - Fund for Scientific Research, Flanders - Belgium - Optimization and implementation of a control system aiming the normalization of glycemia in critically ill patients. G.0557.08 (2008 - 2011)
• FWO - Fund for Scientific Research, Flanders, Belgium - Learning in large relational databases with an application in intensive care medicine. G.0310.08 (2008 - 2011)
• FWO - Fund for Scientific Research, Flanders, Belgium - Signal transduction pathways and cellular and molecular mechanisms behind improved survival of critial illness. G.0533.06 (2006 - 2009)
• FWO - Fund for Scientific Research, Flanders, Belgium - Regulation of the thyroid axis during critical illness: an exploration of the central and peripheral alterations in the low T3 syndrome. G.0258.05 (2005 - 2008)
• FWO - Fund for Scientific Research, Flanders, Belgium - Study of the mechanisms which underly the life-saving effects of strict glycemic control with insulin in critically ill patients. G.0278.03 (2003-2006)
• FWO - Fund for Scientific Research, Flanders, Belgium - Control for intensive care glycemia. G.0491.03 (2003-2006) )
• FWO - Fund for Scientific Research, Flanders, Belgium - G.0144.00 (2000-2003)
• FWO - Fund for Scientific Research, Flanders, Belgium - G.0162.96 (1996-1999)
• FWO - Fund for Scientific Research, Flanders, Belgium - Clinical Research Investigator G.3C05.95N (1995-2004)
• Research Grant from the Belgian Study Group for Pediatric Endocrinology (1994, 1995, 1996)

European Funding

• EU KP6-IST - EU Information Society Technologies : “CLINICIP: Closed Loop Insulin Infusion for Critically Ill Patients”       contract nr. 506965  (CLINICIP) (2004-2008)

 

 

FELLOWSHIPS

Doctoral fellowships

• Jan Gunst - FWO fellowship: Prevention of glucose toxicity prevents renal damage during critical illness: mechanistic studies in a rabbit model.  (01/10/2008-30/09/2012)
• Marijke Gielen - FWO fellowship: Strict glycemic control with intensive insulin therapy in critically ill children: impact on outcome, inflammatory response and the neuroendocrine axes. (01/10/2008-30/09/2012)
• Catherine Ingels - KOF fellowship: Modulation of late innate immune responses in critical illness: impact of insulin and vitamin D (01/04/2009-31/03/2013)
• Geert Meyfroidt - KOF and clinical FWO fellowship (3M050541): Developing significant predictive models in critical illness. Promotion date 02/03/2010
• Dirk Vlasselaers - KOF and clinical FWO fellowship (3M050600): Tight glycemic control with intensive insulin therapy: Effects on inflammation, endothelial and myocardial function and the facilitation of clinical implementation. Promotion date 22/10/2008
• Yves Debaveye - FWO fellowship: The low T3 syndrome during prolonged critical illness. Promotion date 17/09/2007
• Dieter Mesotten - FWO fellowship and Collen Research fund : Mechanisms of growth hormone- and insulin- induced alterations in metabolism during critical illness. Promotion date 26/11/2003

Postdoctoral fellowships

• FWO clinical researcher: Liver dysfunction and its hormonal regulation during acute and protracted critical illness. Dieter Mesotten (01/10/2012-30/09/2017)
• BOF- PDM kort-postdoc fellowship: The pathogenesis of the non-thyroidal illness syndrome: from premature birth to adult critical illness. Liese Mebis (01/10/10-30/09/11)
• BOF- F+postdoc fellowship: Bone metabolism and repair during critical illness. Helen Owen (01/03/2010-28/02/2011)
• FWO clinical research investigator: Calcium and bone homeostasis in acute and prolonged critical illness. Sophie Van Cromphaut (01/10/2008-30/09/2013)
• KOF clinical researcher: Liver dysfunction and its hormonal regulation during acute and protracted critical illness. Dieter Mesotten (01/10/2008-30/09/2010)
• FWO postdoc fellowship: Impact of metabolic interventions on the endocrine system of the critically ill. Lies Langouche- (01/10/2008-30/09/2011)
• BOF postdoc fellowship: Mitochondrial abnormalities in critical illness: role in organ failure and mortality, underlying mechanisms and therapeutic perspectives. Ilse Vanhorebeek (01/10/2008-30/09/2009)
• FWO postdoc fellowship: Molecular and biochemical pathways to improvement of survival and reduced morbidity in critial illness: effects of intensive insulin therapy. Ilse Vanhorebeek (01/10/2005-30/09/2008)
• FWO postdoc fellowship: Mechanisms of action underlying the beneficial effects of strict normalization of blood glucose level with insulin on morbidity and mortality of critical illness. Lies Langouche (01/10/2004-30/09/2008)